STOCK TITAN

[8-K] Newmark Group, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Barclays PLC (BCS) has filed a Form 6-K confirming the launch of its new on-market share buy-back programme.

  • Maximum consideration: £1.0 billion.
  • Period: 30 Jul 2025 – 23 Apr 2026 (subject to continuing regulatory approval).
  • Execution agent: Citigroup Global Markets Limited will act as riskless principal, deciding trades independently of Barclays.
  • Authorisation: Programme operates under the 7 May 2025 AGM authority and all applicable UK Listing Rules and MAR requirements.
  • Volume cap: up to 1,436,786,392 ordinary shares (25 p nominal) may be repurchased; every share bought will be cancelled, directly reducing outstanding share capital.
  • Geographic scope: Purchases restricted to the London Stock Exchange; none will occur in the United States or in respect of ADRs.

The company states the purpose of the buy-back is to shrink share capital, which can lift per-share metrics and signal surplus capital capacity.

Barclays PLC (BCS) ha presentato un modulo 6-K confermando l'avvio del suo nuovo programma di riacquisto azionario sul mercato.

  • Considerazione massima: £1,0 miliardo.
  • Periodo: dal 30 luglio 2025 al 23 aprile 2026 (soggetto a continua approvazione normativa).
  • Agente esecutore: Citigroup Global Markets Limited agirà come principale senza rischio, decidendo le operazioni in modo indipendente da Barclays.
  • Autorizzazione: Il programma opera sotto l'autorità dell'assemblea generale del 7 maggio 2025 e in conformità con tutte le regole di quotazione del Regno Unito e i requisiti MAR applicabili.
  • Limite di volume: possono essere riacquistate fino a 1.436.786.392 azioni ordinarie (valore nominale 25 p); ogni azione acquistata sarà cancellata, riducendo direttamente il capitale sociale in circolazione.
  • Ambito geografico: Gli acquisti saranno limitati alla Borsa di Londra; nessun acquisto avverrà negli Stati Uniti o riguardo agli ADR.

L'azienda dichiara che lo scopo del riacquisto è ridurre il capitale sociale, il che può migliorare le metriche per azione e indicare una capacità di capitale in eccesso.

Barclays PLC (BCS) ha presentado un Formulario 6-K confirmando el lanzamiento de su nuevo programa de recompra de acciones en el mercado.

  • Consideración máxima: £1.0 mil millones.
  • Periodo: del 30 de julio de 2025 al 23 de abril de 2026 (sujeto a la aprobación regulatoria continua).
  • Agente ejecutor: Citigroup Global Markets Limited actuará como principal sin riesgo, decidiendo las operaciones de forma independiente a Barclays.
  • Autorización: El programa opera bajo la autoridad de la junta general anual del 7 de mayo de 2025 y cumpliendo con todas las reglas de cotización del Reino Unido y los requisitos MAR aplicables.
  • Límite de volumen: se pueden recomprar hasta 1.436.786.392 acciones ordinarias (valor nominal 25 p); cada acción comprada será cancelada, reduciendo directamente el capital social en circulación.
  • Ámbito geográfico: Las compras estarán restringidas a la Bolsa de Valores de Londres; no se realizarán compras en Estados Unidos ni respecto a ADRs.

La compañía declara que el propósito de la recompra es reducir el capital social, lo que puede mejorar los indicadores por acción y señalar una capacidad de capital excedente.

Barclays PLC (BCS)는 새로운 시장 내 자사주 매입 프로그램 개시를 확인하는 Form 6-K를 제출했습니다.

  • 최대 금액: 10억 파운드.
  • 기간: 2025년 7월 30일 ~ 2026년 4월 23일 (지속적인 규제 승인에 따름).
  • 집행 대리인: Citigroup Global Markets Limited가 무위험 원칙으로서 Barclays와 독립적으로 거래를 결정합니다.
  • 승인: 본 프로그램은 2025년 5월 7일 주주총회 권한 및 모든 관련 영국 상장 규칙과 MAR 요건에 따라 운영됩니다.
  • 거래 한도: 최대 1,436,786,392주(액면가 25펜스)를 재매입할 수 있으며, 매입된 모든 주식은 취소되어 발행주식 수가 직접 감소합니다.
  • 지리적 범위: 매수는 런던 증권거래소로 제한되며, 미국 내 또는 ADR에 대한 매수는 없습니다.

회사는 자사주 매입 목적이 자본을 축소하여 주당 지표를 향상시키고 잉여 자본 여력을 나타내기 위함이라고 밝혔습니다.

Barclays PLC (BCS) a déposé un formulaire 6-K confirmant le lancement de son nouveau programme de rachat d'actions sur le marché.

  • Montant maximum : 1,0 milliard de livres sterling.
  • Période : du 30 juillet 2025 au 23 avril 2026 (sous réserve d'une approbation réglementaire continue).
  • Agent d'exécution : Citigroup Global Markets Limited agira en tant que principal sans risque, décidant des transactions de manière indépendante de Barclays.
  • Autorisation : Le programme fonctionne sous l'autorité de l'assemblée générale du 7 mai 2025 et respecte toutes les règles de cotation britanniques ainsi que les exigences MAR applicables.
  • Plafond de volume : jusqu'à 1 436 786 392 actions ordinaires (valeur nominale 25 p) peuvent être rachetées ; chaque action achetée sera annulée, réduisant directement le capital social en circulation.
  • Portée géographique : Les achats sont limités à la Bourse de Londres ; aucun achat ne sera effectué aux États-Unis ni concernant les ADR.

La société indique que l'objectif du rachat est de réduire le capital social, ce qui peut améliorer les indicateurs par action et signaler une capacité excédentaire de capital.

Barclays PLC (BCS) hat ein Formular 6-K eingereicht, das den Start seines neuen Aktienrückkaufprogramms am Markt bestätigt.

  • Maximale Gegenleistung: £1,0 Milliarde.
  • Zeitraum: 30. Juli 2025 – 23. April 2026 (vorbehaltlich fortlaufender behördlicher Genehmigung).
  • Ausführungsagent: Citigroup Global Markets Limited wird als risikoloser Principal agieren und die Trades unabhängig von Barclays entscheiden.
  • Genehmigung: Das Programm wird unter der Genehmigung der Hauptversammlung vom 7. Mai 2025 und allen anwendbaren UK-Listing-Regeln sowie MAR-Anforderungen durchgeführt.
  • Volumenlimit: Es können bis zu 1.436.786.392 Stammaktien (Nennwert 25 Pence) zurückgekauft werden; jede gekaufte Aktie wird annulliert, wodurch das ausstehende Aktienkapital direkt reduziert wird.
  • Geografischer Umfang: Käufe sind auf die Londoner Börse beschränkt; keine Käufe in den USA oder bezüglich ADRs.

Das Unternehmen erklärt, dass der Zweck des Rückkaufs darin besteht, das Aktienkapital zu verringern, was die Kennzahlen je Aktie verbessern und eine überschüssige Kapitalausstattung signalisieren kann.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: £1bn buy-back signals capital flexibility and supports EPS; modest versus market cap but shareholder-friendly.

The £1,000m ceiling equates to roughly 3-4% of Barclays’ current market capitalisation, offering a tangible yet not transformative reduction in share count. Using an external agent and preset parameters limits execution risk and potential market abuse concerns. Cancellation of shares ensures the benefit flows directly to continuing holders rather than facilitating employee schemes. No impact on ADR float is expected. Capital ratios will fall marginally, but management’s willingness to return cash implies regulatory headroom remains comfortable. Overall, the disclosure is modestly positive for equity holders.

Barclays PLC (BCS) ha presentato un modulo 6-K confermando l'avvio del suo nuovo programma di riacquisto azionario sul mercato.

  • Considerazione massima: £1,0 miliardo.
  • Periodo: dal 30 luglio 2025 al 23 aprile 2026 (soggetto a continua approvazione normativa).
  • Agente esecutore: Citigroup Global Markets Limited agirà come principale senza rischio, decidendo le operazioni in modo indipendente da Barclays.
  • Autorizzazione: Il programma opera sotto l'autorità dell'assemblea generale del 7 maggio 2025 e in conformità con tutte le regole di quotazione del Regno Unito e i requisiti MAR applicabili.
  • Limite di volume: possono essere riacquistate fino a 1.436.786.392 azioni ordinarie (valore nominale 25 p); ogni azione acquistata sarà cancellata, riducendo direttamente il capitale sociale in circolazione.
  • Ambito geografico: Gli acquisti saranno limitati alla Borsa di Londra; nessun acquisto avverrà negli Stati Uniti o riguardo agli ADR.

L'azienda dichiara che lo scopo del riacquisto è ridurre il capitale sociale, il che può migliorare le metriche per azione e indicare una capacità di capitale in eccesso.

Barclays PLC (BCS) ha presentado un Formulario 6-K confirmando el lanzamiento de su nuevo programa de recompra de acciones en el mercado.

  • Consideración máxima: £1.0 mil millones.
  • Periodo: del 30 de julio de 2025 al 23 de abril de 2026 (sujeto a la aprobación regulatoria continua).
  • Agente ejecutor: Citigroup Global Markets Limited actuará como principal sin riesgo, decidiendo las operaciones de forma independiente a Barclays.
  • Autorización: El programa opera bajo la autoridad de la junta general anual del 7 de mayo de 2025 y cumpliendo con todas las reglas de cotización del Reino Unido y los requisitos MAR aplicables.
  • Límite de volumen: se pueden recomprar hasta 1.436.786.392 acciones ordinarias (valor nominal 25 p); cada acción comprada será cancelada, reduciendo directamente el capital social en circulación.
  • Ámbito geográfico: Las compras estarán restringidas a la Bolsa de Valores de Londres; no se realizarán compras en Estados Unidos ni respecto a ADRs.

La compañía declara que el propósito de la recompra es reducir el capital social, lo que puede mejorar los indicadores por acción y señalar una capacidad de capital excedente.

Barclays PLC (BCS)는 새로운 시장 내 자사주 매입 프로그램 개시를 확인하는 Form 6-K를 제출했습니다.

  • 최대 금액: 10억 파운드.
  • 기간: 2025년 7월 30일 ~ 2026년 4월 23일 (지속적인 규제 승인에 따름).
  • 집행 대리인: Citigroup Global Markets Limited가 무위험 원칙으로서 Barclays와 독립적으로 거래를 결정합니다.
  • 승인: 본 프로그램은 2025년 5월 7일 주주총회 권한 및 모든 관련 영국 상장 규칙과 MAR 요건에 따라 운영됩니다.
  • 거래 한도: 최대 1,436,786,392주(액면가 25펜스)를 재매입할 수 있으며, 매입된 모든 주식은 취소되어 발행주식 수가 직접 감소합니다.
  • 지리적 범위: 매수는 런던 증권거래소로 제한되며, 미국 내 또는 ADR에 대한 매수는 없습니다.

회사는 자사주 매입 목적이 자본을 축소하여 주당 지표를 향상시키고 잉여 자본 여력을 나타내기 위함이라고 밝혔습니다.

Barclays PLC (BCS) a déposé un formulaire 6-K confirmant le lancement de son nouveau programme de rachat d'actions sur le marché.

  • Montant maximum : 1,0 milliard de livres sterling.
  • Période : du 30 juillet 2025 au 23 avril 2026 (sous réserve d'une approbation réglementaire continue).
  • Agent d'exécution : Citigroup Global Markets Limited agira en tant que principal sans risque, décidant des transactions de manière indépendante de Barclays.
  • Autorisation : Le programme fonctionne sous l'autorité de l'assemblée générale du 7 mai 2025 et respecte toutes les règles de cotation britanniques ainsi que les exigences MAR applicables.
  • Plafond de volume : jusqu'à 1 436 786 392 actions ordinaires (valeur nominale 25 p) peuvent être rachetées ; chaque action achetée sera annulée, réduisant directement le capital social en circulation.
  • Portée géographique : Les achats sont limités à la Bourse de Londres ; aucun achat ne sera effectué aux États-Unis ni concernant les ADR.

La société indique que l'objectif du rachat est de réduire le capital social, ce qui peut améliorer les indicateurs par action et signaler une capacité excédentaire de capital.

Barclays PLC (BCS) hat ein Formular 6-K eingereicht, das den Start seines neuen Aktienrückkaufprogramms am Markt bestätigt.

  • Maximale Gegenleistung: £1,0 Milliarde.
  • Zeitraum: 30. Juli 2025 – 23. April 2026 (vorbehaltlich fortlaufender behördlicher Genehmigung).
  • Ausführungsagent: Citigroup Global Markets Limited wird als risikoloser Principal agieren und die Trades unabhängig von Barclays entscheiden.
  • Genehmigung: Das Programm wird unter der Genehmigung der Hauptversammlung vom 7. Mai 2025 und allen anwendbaren UK-Listing-Regeln sowie MAR-Anforderungen durchgeführt.
  • Volumenlimit: Es können bis zu 1.436.786.392 Stammaktien (Nennwert 25 Pence) zurückgekauft werden; jede gekaufte Aktie wird annulliert, wodurch das ausstehende Aktienkapital direkt reduziert wird.
  • Geografischer Umfang: Käufe sind auf die Londoner Börse beschränkt; keine Käufe in den USA oder bezüglich ADRs.

Das Unternehmen erklärt, dass der Zweck des Rückkaufs darin besteht, das Aktienkapital zu verringern, was die Kennzahlen je Aktie verbessern und eine überschüssige Kapitalausstattung signalisieren kann.

0001690680false00016906802023-07-282023-07-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 30, 2025
 
Newmark Group, Inc.
(Exact name of Registrant as specified in its charter)
 
   
Delaware001-3832981-4467492
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
125 Park Avenue, New York, NY 10017
(Address of principal executive offices)
Registrant’s telephone number, including area code: (212372-2000
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading
Symbol(s)
 Name of each exchange on which registered
Class A Common Stock, $0.01 par value NMRK The NASDAQ Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐










Item 2.02.     Results of Operations and Financial Condition.
On July 30, 2025, Newmark Group, Inc. (the “Registrant,” “we,” “us,” “Newmark,” or the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Except as indicated below, the information in this Item 2.02 and Exhibit 99.1 attached to this Current Report on Form 8-K are being furnished under Item 2.02 of Form 8-K. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as expressly set forth by specific reference in such filing and as set forth below.

FILED INFORMATION

The information set forth under the heading “Dividend Information” set forth in Exhibit 99.1 to this Current Report on Form 8-K is being filed under Item 2.02 of Form 8-K and shall be deemed incorporated by reference in any filing under the Securities Act, except as expressly set forth by specific reference in such filing. All other information set forth in Exhibit 99.1 is being furnished.

DISCUSSION OF FORWARD-LOOKING STATEMENTS ABOUT NEWMARK

Statements in the press release in Exhibit 99.1 of this Current Report on Form 8-K regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.

Item 8.01. Other Events

The Board of Directors (the “Board”) of the Company has set the date of the Company’s 2025 Annual Meeting of Stockholders (“Annual Meeting”) for November 20, 2025. The exact time and place of the 2025 Annual Meeting will be specified in our Notice of 2025 Annual Meeting and related proxy statement for the 2025 Annual Meeting.

Because the date of the 2025 Annual Meeting is more than 30 days after the first anniversary of our 2024 Annual Meeting, the Board has set a new deadline for the receipt of stockholder proposals submitted for the 2025 Annual Meeting pursuant to Rule 14a-8 under the Exchange Act (“Rule 14a-8”). If a stockholder desires to present a proposal for inclusion in our proxy statement for the 2025 Annual Meeting pursuant to Rule 14a-8, the proposal must be submitted in writing to us for receipt not later than August 9, 2025, which is 10 days following the date hereof. Additionally, to be included in our proxy materials, proposals must comply with the proxy rules relating to stockholder proposals in Rule 14a-8. If a stockholder fails to provide such notice, the proposal may not be addressed in our proxy materials and the proxies may exercise their discretionary voting authority if the proposal is raised at the 2025 Annual Meeting. Proposals should be sent to Newmark Group, Inc., 125 Park Avenue New York, New York 10017, Attention: Corporate Secretary.




Our bylaws provide that if our Annual Meeting is held on a date that is less than 60 days after the anniversary of the prior year’s Annual Meeting, for nominations or other business to be properly brought by a stockholder, notice in writing to the Secretary of the Company must be received not later than the close of business on the 120th day prior to the anniversary of the date of the proxy statement for the prior year’s Annual Meeting. As disclosed in the proxy statement for the 2024 Annual Meeting, stockholders who wished to raise a proposal for consideration at the 2025 Annual Meeting, but who did not wish submit a proposal for inclusion in our proxy material pursuant to Rule 14a-8, needed to comply with our bylaws and deliver us a copy of their proposal no later than May 9, 2025.

Item 9.01. Financial Statements and Exhibits
 
(d) Exhibits
The exhibit index set forth below is incorporated by reference in response to this Item 9.01.

EXHIBIT INDEX

Exhibit No. Description
99.1
Newmark Group, Inc. press release dated July 30, 2025
104The cover page from this Current Report on Form 8-K, formatted in Inline XBRL



 
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
 



  
Newmark Group, Inc.
  
Date: July 30, 2025  
By:
 /s/ Michael J. Rispoli
   Name: Michael J. Rispoli
   Title: Chief Financial Officer






[Signature Page to Form 8-K, dated July 30, 2025, regarding Newmark Group, Inc.’s second quarter ended June 30, 2025 Earnings Release]

Newmark Group

NASDAQ:NMRK

NMRK Rankings

NMRK Latest News

NMRK Latest SEC Filings

NMRK Stock Data

2.51B
153.63M
15.81%
68.62%
2.62%
Real Estate Services
Real Estate Agents & Managers (for Others)
Link
United States
NEW YORK